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The fragments resulting from the enzymic digestion of human immunoglobu- 
fin  G  (IgG)  have  been  extensively  studied  with  respect  to  immunological 
properties (for review,  see Porter and Press, reference 1). Papain cleaves IgG 
in the presence of cysteine into  three fragments  (2-4),  two Fab and one Fc 
(for nomenclature,  see reference 5).  The Fab fragments,  though monovalent, 
retain full combining  specificity for antigen (2), whereas the Fc fragment con- 
tains most of the antigenic determinants of IgG. Pepsin cleaves IgG to yield 
a divalent active fragment F(abt)~,  and smaller fragments derived from the Fc 
portion of the molecule (6).  Reduction of IgG under mild  conditions yields 
two types of chains,  heavy and light,  which can be separated by gel filtration 
(7).  Some  of  the  biological  properties  of  native  immunoglobulins,  such  as 
complement-binding  capacity,  skin-fixing  ability,  and  antigenic  specificities 
have  been shown  to be localized  in  individual  subunits  and  chains  (8-11). 
Chemical reagents which cleave selectively peptide bonds adjacent to specific 
amino acids have been helpful in recent years ill structural studies of proteins. 
Cleavage of methionyl bonds with  cyanogen bromide  (CNBr)  has been the 
method  of preference,  as practically no side reactions  take place  (12).  This 
reagent has been used successfully in the determination of amino acid sequences 
ill protein chains,  in the proof of the nonidentity of chains,  and in drawing 
conclusions  about protein conformation (literature  cited in reference 13). Re- 
cently, studies  on  the  amino  acid  sequence and  peptide  maps  of  immuno- 
globulin chains, using cyanogen bromide cleavage, have been reported (14-18). 
Whereas,  in studies of the amino acid sequences of proteins,  the efficiency 
of the method depends on the quantitative cleavage of peptide bonds adjacent 
to  all  methionine  residues in  the molecule,  for studies  of  the  correlation  of 
biological  activity of a protein with its chemical structure,  a limited cleavage 
may be of interest.  Previous reports from  this  laboratory  described  CNBr 
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cleavage  of  rabbit  IgG  under  milder  conditions,  leading  to  a  preferential 
destruction of that part of the molecule with which Fc is associated, and to the 
formation of "5S" fragments which retained antibody activity (13,  19).  Such 
milder conditions were also used in studies of  the amino acid composition of 
different moieties of two antibodies (20). 
The present investigation is concerned with similar cleavage of human IgG 
and indicates that, in resemblance to the rabbit protein, most of the antibody 
activity of human IgG is retained after  cleavage with  CNBr.  In contrast to 
the antibody activity, which is known to be located in the Fab fragment, other 
biological properties  which  are  related  to  the  Fc  fragment,  such  as  genetic 
markers and other antigenic determinants, as well as complement-binding  and 
skin-fixation sites, are essentially lost during the CNBr cleavage. 
In accordance with the accepted denotation of F(ab')2 for 5S fragments ob- 
tained by pepsin digestion of IgG (5), we denote similar fragments, having two 
antibody sites, obtained by CNBr cleavage, as F(ab")~. 
Materials and Methods 
Immunoglobulin G.--Normal human IgG was prepared from outdated  human plasma by 
precipitation  with  ammonium sulfate  (40% saturation).  The washed precipitate  was dis- 
solved in water and dialyzed exhaustively against large volumes of 0.15 •  NaCI followed by 
short  dialysis against  0.0167 M phosphate  buffer, pH  6.3  (during the  dialysis fibrinogen 
precipitated). The clear solution was chromatographed in the same buffer on diethylamino- 
ethylcellulose (Bio-Rad Laboratories, Inc., Richmond, Calif.) according to Levy and Sober 
(21), and the fraction eluted was concentrated by vacuum dialysis. 
Human IgG with antibody activity was prepared in a similar way, starting from serum 
instead of plasma. Thus, IgG with antistreptolysin activity was isolated from high titer serum 
of patients suffering from rheumatic fever, and anti-A group IgG was isolated from sera of 
individuals of O blood group. 
The immunoglobulin solutions were stored in the frozen state. The protein concentration 
was  determined  spectrophotometrically,  assuming  a  specific extinction  coefficient  of 
E~% =  13.8 at 280 m# (22). 
Cyanogen Bromide Treatment of IgG.--A solution of IgG (about 50 mg/ml) was mixed with 
an equal volume of a freshy prepared 0.15 ~ solution of crystalline CNBr (Eastman Kodak 
Co., Rochester, N. Y.) in 0.1 M HC1. The mixture was allowed to stand in a tightly closed 
glass-stoppered container at room temperature for 4 hr. 
Column Fractionation of the CNBr  Digest.--The reaction  mixture described above  (6-8 
ml, containing about 200 rag) was applied to a Sephadex G-100 (Pharmacia, Uppsala, Sweden) 
column (2.5 X  150 cm) previously equilibrated with 0.05 M  HC1. Elution was carried out at 
4°C with 0.05 M HC1, and the absorbancy of the effluent solution was measured at 280 m#. 
Amino Acid Analysis.--Amino acid analyses (23) were performed on the Beckman/Spinco 
automatic  amino  acid analyzer,  model 120B, after  hydrolysis under reduced  pressure in 
constant boiling hydrochloric acid (6 N) for 22 hr at ll0°C. 
Physical Methods.--Spectrophotometric  measurements were made on a Zeiss model PMQII 
spectrophotometer, at approximately 25  °, with quartz cells of 1 cm light path. 
Sedimentation measurements were carried out  in a  Spinco model E  ultracentrifuge,  at 
20--22  °,  with  the  Schlieren optical  system. The samples were sedimented  at  59,780 rpm. 
Measurements were made at various pH values ranging from 2-9, in both aqueous and urea 
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Starch gel electrophoresis in 8 ~  urea formate buffer, was carried out as described by Edel- 
man and Poulik (24). 
Free boundary electrophoresis was carried out in a  Tiselius apparatus using a  2  ml cell 
and 0.1 ~s barbital buffer, pH 8.6, as described by Longsworth (25). 
Antisera.--Human  IgG (prepared as mentioned above) or human light chains (prepared 
according to Fleischman et al., reference 26)  were used for the preparation of goat antisera. 
Immunization was accomplished by injection at multiple intradermal sites of a total amount 
of 30 mg protein in complete Freund's adjuvant (Difco Laboratories, Inc., Detroit. Mich.). 
Blood was collected from the external jugular vein. Either the antisera or  IgG isolated from 
them as described above for human IgG, were used in the various experiments. 
Gd Diffu*ion.--This was carried out in agar gel in 0.05 M barbital buffer, pH  8.6, accord- 
ing to Ouchterlony (27). 
Complement-Binding Activity.--The procedure  was  essentially according to  Mayer et  al. 
(28,29),  using lyophilized guinea pig  complement and  anti-sheep hemolysin  (Difco).  In  a 
typical experiment various amounts (2-4 mg) of IgG, both native and CNBr-treated, were 
mixed in the cold with a constant amount  (22  C'Hs0  units) of complement. Following incu- 
bation for 30 min at 37°C and storage in the cold room overnight, the solutions were diluted 
to yield a  concentration suitable for the estimation of the residual activity of complement. 
Antistreptolysin  Activity.--Thls was  determined  according  to  Rantz  and  Randall  (30). 
Solutions of 1 ml containing various amounts (0.1-50/~g) of IgG, both native and subjected 
to  various treatments, were  mixed with 0.5  ml of  Bacto  Streptolysin O  Reagent  (Difco). 
Following 15  min at  37°C,  05 ml of 5% rabbit erthyrocytes suspension was added and the 
mixtures were incubated at 37°C  for 45  rain. The extent of hemolysis was determined from 
the absorbancy of the supernatant fluids at 541 m#. 
Isohemagglutinin Activity.--This was determined (31), using IgG preparations from a  type 
O individual, and fresh human erythrocytes from type A individuals. IgG preparations, both 
native and treated, were brought to pH 8.5,  and mixed in twofold serial dilutions in saline, 
with equal volumes of a 2% suspension of erythrocytes. The mixtures were kept at 37°C for 
1 hr and centrifuged thereafter  for 5 rain at 1000 rpm. Hemagghitination  was graded macroscop- 
ically from 1+ to 3+. 
Reverse Passive Cutaneous Anaphylaxis  (RPCA).--RPCA  experiments were performed in 
guinea pigs according to Ovary  (32), using human IgG and CNBr-treated IgG as antigens, 
and either the IgG fraction isolated from a  goat antiserum to  human immunoglobulin G, 
or goat antiserum to human light chain, as antibody. 
Reaction  with  Anti-Human  IgG  Factor.--Binding  capacity  to  antiglobulin factors  was 
determined by inhibition of the latex fixation. The latex fixation test was carried out accord- 
ing to  Singer et al.  (33).  Solutions of the native or  treated IgG were mixed with an equal 
volume of a  serum from a  patient  with rheumatoid arthritis and maintained 1 hr at room 
temperature. To 0.2 ml samples of serial dilutions of these  mixtures, 0.2 ml of IgG-coated 
latex was added. Mter 90 rain incubation at  56°C the mixtures were kept overnight at 4°C, 
centrifuged for 5 mill at 2000 rpm and graded macroscopically. 
Genetic Factors.--Four  genetic factors,  Gin(l), Gm(2), Gin(4), and Gin(12) (nomenclature 
recommended in reference 34), were determined on both  native and treated IgG preparations 
by the method of Harboe (35).  For each Gm factor determination, one drop of  the sample to 
be tested was mixed on a  microscopic slide with  one drop of the respective anti-Gm serum 
and one drop of a 0.5% suspension of anti-Rh-coated erythrocytes.  Mter 5-10 rain at room 
temperature, the agglutination was read macroscopicaUy. The specific anti-Gm reagents were 
obtained  from  Dr.  Ropartz,  of  the Centre  Departamental  de Transfusion Sanguine et  de 
Genetique Humaine, Rouen, France, whereas the  specific  anti-Rh sera were purchased from 
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I~ESULTS 
Cleavage of Human IgG by Cyanogen Bromide 
Treatment of human IgG with cyanogen bromide under the same conditions 
as described for rabbit IgG (13), namely in 0.3 M HCI, led to almost complete 
precipitation of the protein. In control experiments (in the absence of CNBr) 
similar precipitation occurred,  indicating  that  this  phenomenon  was  due  to 
TABLE I 
Amino Acid Composition of Human IgG and Products of CNBr Digestion* 
Amino acid residue  Human  IgG~/  IgG from pooled  CNBr digest  F(abn)2  normal serum 
Lys 
His 
Arg 
Asp 
Thr§ 
Ser§ 
Glu 
Pro 
Gly 
Ala 
Val 
Met 
ILeu 
Leu 
Tyr 
Phe 
82 
27 
39 
102 
105 
157 
130 
98 
89 
70 
108 
I1 
29 
99 
54 
42 
79 
23 
40 
102 
102 
144 
128 
98 
89 
71 
117 
11.8 
30 
99 
55 
46 
80 
24 
4O 
105 
105 
144 
129 
97 
89 
74 
121 
5.8 
30 
96 
51 
48 
55 
16 
27 
72 
79 
113 
92 
75 
67 
54 
82 
4 
21 
73 
41 
32 
* The results were calculated from the analysis after hydrolysis for 22 hr, assuming  the 
molecular weight of intact IgG to be 150,000, and that of F(ab")~ to be 100,000. The values 
in the table denote number of residues per molecule. 
~t Data from Crumpton and Wilkinson (36). 
§ The values were not corrected for loss during hydrolysis. 
the  acidic conditions  of  the  reaction.  Milder  acidic medium  was,  therefore, 
used for the cleavage of human IgG with CNBr,  than was the case for rabbit 
IgG. No precipitation occurred and yet successful partial cleavage of human 
IgG  was  obtained  upon  treatment  for  4  hr  in  0.07 ~s  CNBr-0.05 ~r  HC1. 
Amino acid analysis of the lyophilized reaction mixture,  as compared to  the 
native IgG  (Table I),  demonstrated  that  half  of  the  methionine residues in 
the original molecule had disappeared, while no change occurred in the contents 
of any other amino acid. 
Attempts to remove the CNBr by dialysis against various buffers, ranging 
from 0.05 M acetate buffer,  pH 4.5  to 0.1 M barbital buffer,  pH 8.6,  resulted MIRA  LAHAV,  RUTH  ARNON,  AND  MICHAEL  SELA  791 
invariably in precipitation  of  the protein.  Upon  neutralization by one  step 
addition of 1 v~ NaOH to pH 8, followed by dialysis against 0.5 M NaC14).02 M 
tris buffer, pH 8.2,  the product remained in solution. However, the presence 
of large amounts of aggregates in such preparations, accompanying a product 
sedimenting  with  5.8S,  was  demonstrated  both  by ultracentrifugal  analysis 
(Fig.  1,  D)  and by measuring  the ratio of their absorbancies  at wavelengths 
250 and 280 m/z; this ratio was 1.17, as compared to 2.55 for native IgG. The 
formation of these aggregates could not be avoided by addition of 0.4 M sodium 
decyl sulfate  to  the  reaction mixture prior  to  the  dialysis  (Fig.  1,  E),  nor 
could they be eliminated by gel filtration on Sephadex G-100 or G-200 in 0.5 ~t 
NaC1-0.02 v[ tris buffer, pH 8.2,  (Fig.  1,  F)  or in 1 ~  acetic acid (Fig.  1,  C). 
The method  successfully used  for  the  removal of lower molecular weight 
peptides as well as most of the CNBr from the original acidic reaction mixture 
was gel filtration on Sephadex G-100 in 0.05 ~  HC1.  The elution pattern of a 
typical gel filtration is shown in Fig. 2;  the main fraction recovered from the 
column was  about  70%  of  the  digestion mixture applied.  Lyophilization of 
this product resulted in the removal of HC1 and of the remainder CNBr. The 
water-soluble  product  obtained,  migrated  in  the  ultracentrifuge  after  ex- 
haustive dialysis against 0.03 M NaC1 (pH 5.8)  as one main peak, with s20.  ~o = 
4.5S (Fig.  1,  G). Native IgG migrated in 0.03 M NaCI with s2o,w =  5.6S.  The 
product with S2o,,o =  4.5S,  to be denoted F(ab")~, had a  ratio of absorbancy 
at 250 and 280 mtt of 2.25. 
Physical and Chemical Characterization of F(ab")2 
Solubility.--The  F(ab")~,  obtained  by  lyophilization  was  readily  soluble 
in distilled water, yielding a solution of pH 2. It remained soluble after dialysis 
against distilled water at pH 5.8 or against 0.03 ~  NaC1, but precipitated upon 
dialysis against 0.15 M NaC1, against 0.01 M tris buffer, pH 7.3, or 0.1 M barbital 
buffer, pH 8.6.  Dialysis against the same barbital buffer after previous raising 
of the pH with 1 M NaOH to pH 9 did not result in precipitation. 
Starch Gel Electrophoresis.--As shown in Fig. 3,  the F(ab")2 preparation ob- 
tained  after the  reaction of IgG with  CNBr  had  a  different electrophoretic 
pattern from that of native human IgG. The main fragment obtained had a 
higher mobility than that of the native protein and it was accompanied by a 
few fast migrating  components.  In  contrast,  IgG  that  was  exposed  to  HC1 
in  the  absence of CNBr,  did  not  show  the presence of any components mi- 
grating  faster  than  the  IgG.  These results  indicate  that  by treatment  with 
CNBr the molecule was cleaved in several places. Both the HC1 control and 
the  CNBr-treated  IgG  contained  several  slow  components,  which  probably 
represent aggregates.  The CNBr-produced fragment, after exposure to pH 9, 
shows more aggregated material than at pH 2. 
Free Boundary  Electrophoresis.--In  0.1 M barbital  buffer, pH  8.6,  F(abtt)2 792  CLEAVAGE  OF  HUMAN  IOG  WITH  CYANOGEN  BROMIDE 
FIo.  1. Photograph of the Schlieren patterns taken in the Spinco model E  ultracentrifuge 
after 32 rain at 59,780 rpm. Sedimentation is from right to left. A, native IgG, and B, native 
antistreptolysin IgG,  were run in 0.15  M NaC1-0.02  ~t phosphate buffer, pH  6.3;  C,  CNBr- 
treated IgG, fractionated on Sephadex G-100 in  1 M acetic acid and run in the same solvent; 
D, CNBr-treated IgG, fractionated on Sephadex G-100; and E, CNBr-treated IgG, fraction- 
ated on Sephadex G-200 in 0.5 M NaC1-0.02 •  tris buffer pH 8.2, and run in the same solvent; 
F,  CNBr-treated  IgG,  neutralized in  presence of 0.1  M sodium decyl sulfate,  fractionated, 
and run as in D.  G, CNBr-treated lgG, fractionated on Sephadex G-100 in 0.05 M HC1 and 
run in 0.03 ~t NaC1 (F(ab")2). MIRA LAHAV~ RUTH ARNON~ AND  MICHAEL SELA  793 
appeared  as  a  homogeneous material with  a  mobility of  #  =  1.25  X  10  -5 
cm2/v sec, as compared to 1.1  X  10  .5 cm2/v sec of the IgG. 
Amino Acid Analysis.--The amino acid analysis of F(ab'r)2 is given in Table 
I.  The  fragment  still  contained  four  methionine  residues  per  a  molecular 
weight of 100,000,  whereas in the original CNBr-cleavage product there were 
E 
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FIG. 2. Gel filtration pattern of the CNBr-digest of human IgG on Sephadex G-100 column 
(2.5 X  150 cm). The column was developed with 0.05 M  HC1. 
Fro. 3. Electrophoresis in 8 •  urea-formic acid starch gel, pH 3.5. A, native IgG; B, IgG 
treated in 0.05 M  HC1 for 20 hr (control); C, aqueous solution at pH 5.8 of CNBr-treated IgG, 
previously fractionated on Sephadex G-100 in 0.05 ~ HCI and lyophilized (F(ab")~); D, same 
as C, in 0.1 M barbital buffer, pH 8.6. 794  CLEAVAGE OF  HUMAN IGG  WITK  CYANOGEN BROMIDE 
six  methionine  residues  per  molecular weight  of  150,000.  Thus,  all  the  me- 
thionine  residues  which  were  not  converted into  homoserine  or  homoserine 
lactone, are preserved in the F(ab")2. 
Ultracentzifugal Analysis.--In Fig. 4  are shown the ultracentrifuge patterns 
in  different media  of F(ab")2,  as  compared to  the  original IgG. In  aqueous 
Fia. 4. Photograph of the Schlieren patterns taken in the Spinco  model E  ultracentrifuge 
after 32  rain at  59,780 rpm. In each pattern the upper curve represents the CNBr-treated 
product and the lower curve represents the native IgG. A, aqueous solution, pH 2; B, aqueous 
solution, pH 5.8; C, 8 M urea. 
solution at pH 2, F(ab')2 sedimented as an almost homogeneous peak of 2.6S, 
in  comparison to  the 5.5S  of native IgG  (Fig. 4,  A).  This acid pH  caused  a 
slight  aggregation  of  the  IgG.  When  tested  in  aqueous  solution  at  pH  5.8 
(Fig.  4,  B),  the  native  IgG had  a  sedimentation  constant  of  6.1S,  whereas 
F(ab")2 showed a  main peak  (4.0S)  with  a  shoulder  (6.1S).  In 8 ~  urea  the 
respective sedimentation constants of the IgG and its cleavage products were 
3.0S  and  2.2S  (Fig.  4,  C).  It  seems,  therefore,  that  under  all  experimental 
conditions tested the sedimentation rate of F(ab")2 is lower than that of the 
original protein, although absolute values are dependent on the solvent. MIRA LAHAV, RUTH ARNON, AND MICHAEL SELA  795 
Biological Properties of F(abr~)2 
Antigenic  Properties.--The  treatment  with  CNBr  under  the  mentioned 
specified  conditions caused a marked decrease in the capacity of IgG to pre- 
cipitate with specific goat antisera against the heavy chain. On the other hand 
the  treated material  retained its  full precipitating  capacity with goat  anti- 
light chain sera.  The reactions were followed both by quantitative precipifin 
reaction and by immunodiffusion in  agar gel.  In  the  quantitative precipitin 
reaction,  F(ab")2  precipitated  in  the  equivalence  zone  27%  of  anti-heavy 
chain antibodies as compared to the native IgG, whereas it precipitated 102 % 
of  anti-light  chain  antibodies.  The  immunodiffusion experiments  (Fig.  5) 
similarly indicated that, whereas native IgG or the HCl-treated control gave 
FIG. 5. Agar gel diffusion of the reaction  of human  IgG, before and  after  treatment with 
CNBr,  with goat antisera  to human  heavy and  fight  chains.  AH, goat  anti-human  heavy 
chain; AL, goat anti-human  light chain; IgG, native IgG; CN, CNBr-treated IgG; HCI, IgG- 
treated  with HC1 in theabsence of CNBr. 
two strong precipitation bands with anti-heavy chain, only a very faint band 
was  observed  with  F(ab")~.  In  contrast,  the  reaction  with  anti-light  chain 
demonstrated total identity between the three materials. 
Residual  Gm  Determinants.--The  various  Gm  factors were  determined in 
two samples of IgG, namely, normal IgG and antistreptolysin IgG. The de- 
terminations were carried out with the native protein,  with the HCl-treated 
control, and with the respective F(ab")2. As shown in Table II,  the  Gm(12) 
factor was  completely abolished by  the  treatment  with  CNBr,  whereas  no 
change was caused by the treatment with HC1 alone. On the other hand Gm(1) 
and Gm(4)  determinants were unaffected by the action of CNBr.  Gm(2) was 
not present on the samples of IgG studied. 
Interaction  with Human Antiglobulin Factors.--The reaction of IgG with the 
anti-3,-globulin factors, present in sera from patients with rheumatoid arthritis, 
has been demonstrated using inhibition of agglutination of latex coated with 
IgG. The inhibitory capacity of native IgG as compared to HCl-treated IgG 
and F(ab")2 is shown in Table III. Whereas the native IgG inhibited the ag- 796  CLEAVAGE  OF  HUMAN  IGG  WITH  CYANOGEN  BROMIDE 
glutination at a titer of 1/80,  no inhibitory effect was caused by F(ab")2. It is 
pertinent  to remark that  the  extent  of inhibition  caused by the HCl-treated 
IgG is even higher  than that caused by the native  material, probably due to 
partial denaturation and aggregation. 
Complement-Binding  Capacity.--Native IgG is capable of nonspecific bind- 
ing of guinea pig complement, a property which is ascribed to possible aggrega- 
tion via Fc portion of the molecule  (37).  This passive binding of complement is 
TABLE II 
The Effect of CNBr Treatment on the Genetic Markers of the Gm Type 
Gm factors  Pooled human IgG  IgG with antistreptolysin activity 
HCl-control  F(ab~)2  F(ab~)2 
Gm(1) 
Gm(12) 
Gm(4) 
Gm(2) 
+ 
+ 
+ 
÷ 
÷ 
Native  HCl-control 
+  + 
+  + 
+  + 
+ 
+ 
TABLE III 
Inhibitory Capacity of Native IgG as Compared to  Treated IgG on Interaction of IgG-Coated 
Latex with Antiglobulin Factors 
Inhibition by 
None 
Native IgG 
HCl-treated IgG 
F(ab")2 
1/10  1/20  1/40  1/80  Dilution* 
-4- 
+ 
1/160  1/320  1/640  1/1280 
F 
+  +  +  ± 
+  +  4-  - 
* Dilutions of the rheumatoid arthritis  serum alone and after mixing with different pro- 
tein preparations. 
decreased upon  treatment  with  acid,  but  much more so by CNBr  cleavage. 
Thus, as seen in Fig. 6, 4 mg of the native IgG caused almost complete inhibi- 
tion of hemolysis, due to extensive binding of  the complement, while the bind- 
ing by F(abn)2 is almost negligible. 
Reverse  Passive Cutaneous A naphylaxis.--In order to study the skin-binding 
capacity of IgG, either native,  or CNBr-treated,  we could  not  use the direct 
passive cutaneous  anaphylaxis,  since  the  pooled normal IgG did  not  possess 
any defined  antibody activity.  Recourse was made,  therefore,  to  the  reverse 
passive cutaneous anaphylaxis (32)  where the IgG was injected intradermally 
as the antigen, while goat antiserum was injected intracardially as the antibody 
source.  The  results  of  this  experiment  with  anti  heavy chain  and  anti  light MIRA LAHAV, RUTH ARNON, AND MICHAEL  SELA  797 
chain sera are shown in Table IV. The reaction with anti-heavy chain measures 
the  skin binding but is dependent also on the residual antigenic activity of 
F(ab'~)~. On the other hand, the reaction with the anti-light chain is a direct 
indication of the skin-binding capacity, since the treated protein had retained 
o 
E 
o 
fl_ 
I00 
75 
50- 
25- 
0 
0 
22  C~H~  units 
4  mq  protein 
-  -  I  I 
0.1  0.2  0.3 
Complement  1/36  (ml) 
FIO. 6. Complement  binding by native IgG (0), HCl-treated IgG (O), and CN-Br-treated 
IgG (A). (X), the titration curve of the complement. 
its full capacity to react with anti-light chain serum. The results show that 
while the native IgG gave a positive reaction with the antisera when injected 
at a level of 0.33 #g or less, F(ab")~ reacted with the anti-heavy chain serum 
only, at a level of 5 ~g, and did not react at all with the anti-light chain serum. 
Antibody  Aclivity.--In  order  to  investigate  whether  antibody activity  of 
IgG is affected by treatment with CNBr, ues was made of IgG samples pre- 
pared from sera possessing specific activity. 
Antislreptolysin Aaivity.--Sera  of patients  suffering from rheumatic fever 798  CLEAVAGE  OF  HUMAN  IGG  WITH  CYANOGEN  BROMIDE 
TABLE  IV 
Rcoerse Passive Cutaneous  Anaphylaxis Reactions 
Diameter of lesion, mm 
Amount of protein 
injected  Challenge with native IgG  Challenge with F(abn)~ 
intradermally 
Anti-heavy chain  Anti-light chain  Anti-heavy chain  Anti-light chain 
~g 
50 
10 
5 
2.5 
1 
0.33 
0.11 
0.036 
15 
15 
14 
12 
12 
8 
Trace 
0 
16 
11 
10 
Not done 
Trace 
Not done 
0 
Not done 
11 
8 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Not done 
0 
Not done 
0 
Not done 
S 
o  y._f. 
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are known for their capacity to react with streptolysin O (38).  Since strepto- 
lysin O  causes hemolysis of human red blood cells,  its interaction with the 
specific antistreptolysin in such sera is manifested by the inhibition of hemoly- 
sis.  Fig.  7  shows  the  extent of hemolysis which was  caused by a  constant 
amount of streptolysin after interaction with increasing quantities of native 
IgG, HCl-treated IgG, or F(ab~)~.  Although a certain decrease in antistrepto- 
lysin activity is observed after the CNBr or HC1 treatment,  the protein still 
retains most of its activity. 
Isohemagglutinin  A ctivity.--The IgG isoagglufinin prepared from a  normal 
type O individual, as well as the F(ab")2 derived from it, were tested for he- 
magglutinating activity using erythrocytes of type A (Table V). The threshold 
concentration of IgG was 0.03 mg/ml and F(ab")~ gave a negative reaction at 
a concentration of 0.04 mg/ml; both gave a  strongly positive reaction at 0.06 
TABLE V 
Isohemagglutination Reaction with IgG and (Fab"), 
Concentration,  mg/ml 
Sample 
0.15  O.l  0.015 
+++  +++ 
+++  +++ 
0.24 
IgG  +++ 
F(ab.)  ~  +++ 
__  __ 
mg/ml, indicating that the capacity to agglutinate the appropriate red blood 
cells was not impaired by the treatment with CNBr. 
DISCUSSION 
The specific reaction of cyanogen bromide with polypeptide chains, leading 
to the selective cleavage of peptide bonds adjacent to the methionine residues, 
necessitates an acid medium. Conditions as drastic as 70% formic acid were 
used for quantitative cleavage of all the methionyl bonds in human as well as 
rabbit IgG (14-17).  Such treatment results in complete loss  of biological ac- 
tivity. On the other hand, treatment of rabbit IgG with CNBr in 0.3 M HC1, 
allowed the cleavage of approximately half of the methionyl bonds in the IgG 
molecule,  yielding a  biologically active  5S  fragment  (denoted  F(ab")~  and 
several smaller peptides (13). 
In the present study it was found that still milder conditions for cleavage 
with CNBr have to be used in the reaction with human IgG, in order to obtain 
a soluble fragment possessing biological activity. When the reaction with CNBr 
was allowed to proceed in 0.05 M  HC1, cleavage indeed took place, as was demon- 
strated both by decrease in the methionine content of the hydrolysate, and 
by starch  gel  electrophoretic and ultracentrifugal analyses.  Gel filtration in 
0.05 M HC1 removed most of the smaller fragments, and yielded a main frac- 800  CLEAVAGE  OF  HUMAN  IGG  WITH  CYANOGEN  BROMIDE 
tion which,  at low pH, appeared as a homogenous  peak in the ultracentrifuge 
(Fig.  4, A). Neutralization by several procedures resulted in formation of ag- 
gregates.  Macroscopic precipitation  of about  70%  of  the  material  occurred 
upon gradual raise  of the pH, whereas adjustment of the solution to pH 8.6 
in one step resulted in a material which,  though soluble,  showed the presence 
of aggregates.  The aggregation  is a process depending not only on the pH but 
on the ionic strength as well. Thus, at pH 5.8 and very low ionic strength, the 
material is mostly in the nonaggregated form (Fig.  1, G), while the extent of 
aggregation  increases  with an increase  in the ionic strength. 
The product of the cleavage of human IgG with CNBr,  sedimenting with 
4.5S in 0.03 M NaCI at pH 5.8, and denoted here F(ab~')2, is analogous to the 
"5S-CNBr" product obtained upon cleavage of rabbit IgG with CNBr (13). 
The lower sedimentation coefficient is due to the changed conditions of the 
ultracentrifugation.  Thus,  intact  human IgG sedimented under  these condi- 
tions (0.03 ~  NaC1 at pH 5.8) with 5.6S. 
The pH profile of the aggregation  of the CNBr-cleavage product is different 
from that of the intact IgG. The latter is known to aggregate at low pH, pre- 
sumably via the Fc fragment, which forms by itself aggregates  at low pH (39). 
Beside sedimentation  in  the ultracentrifuge,  the presence  of aggregates  was 
followed also by comparison of absorbancies at 250 and 280 m/z. The measure- 
ments at 250 m# are much stronger affected by aggregation than those at 280 
m#. 
The F(abtt)2 fragment obtained upon cleavage  with CNBr and isolated by 
gel  filtration  (Fig.  2)  represented  approximatively  70%  of  the  native  IgG. 
It migrated as a homogeneous  material in free boundary electrophoresis but, 
starch  gel  electrophoresis  showed,  in  addition  to  the  main  fraction,  small 
amounts of components with higher  electrophoretic mobility. Thus gel filtra- 
tion did not remove quantitatively the smaller cleavage products. 
The main object of this investigation was to determine to what extent will 
the different biological properties of IgG be affected by cleavage with CNBr. 
The  capacity to react with specific antigen remained practically unchanged, 
as was demonstrated by two independent systems. The samples of IgG used 
for these experiments were not deliberately prepared antisera,  but individual 
sera having  specific  antibody  activity.  The  isoagglutinin  activity  did  not 
change significantly  as the result of the action of CNBr (Table V), whereas only 
a partial decrease in antistreptolysin activity was observed (Fig.  7). The assay 
used for anfistreptolysin activity in this study measures directly the interac- 
tion  of  antigen  and  antibody  and  does  not  require  any  auxiliary  system. 
In a  study performed with a  similar  divalent antibody fraction, obtained by 
treatment  of  human  IgG  with  pepsin,  and  using  the  complement-fixation 
method,  antistreptolysin  activity could not be demonstrated,  due to the in- 
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In contrast to the antibody activity, a drastic change in the various char- 
acteristics  related to the antigenic determinants of the IgG was observed. The 
reaction with specific goat antisera indicated that while the antigenic determi- 
nants on the light chain are present to the full extent on F(ab'~)~, those related 
to the heavy chain are only partially retained. 
In the reverse passive  cutaneous anaphylaxis, the reaction of F(ab")2  was 
almost negative when challenged  either with goat anti-heavy chain or with 
anti-light chain sera. The lack of reaction with the anti-heavy chain could be 
interpreted as due either to the absence of the area of the IgG molecule re- 
sponsible for fixing to skin, or to the loss of the antigenic determinants of the 
heavy chain of human IgG. On the other hand, the negative result with anti- 
light chain demonstrates that the action of CNBr indeed removed the area of 
the IgG molecule responsible for fixation to skin. The lesions obtained upon 
reacting F(abn)~ in high concentration with the anti-heavy chain serum were 
probably due to contamination with some intact IgG. 
Since most of the antigenic determinants of the IgG are assumed to be on the 
Fc portion of the molecule (7), and the skin-binding  capacity is attributed to 
the Fc portion as well (9), it can be concluded that, in the human IgG, as in 
the case of rabbit IgG (13), the CNBr cleavage caused a preferential destruc- 
tion of that portion of the molecule with which Fc is associated. This assump- 
tion is in accord with the finding that F(ab")2 is not capable of reacting with 
antiglobulin factors, in contrast to intact IgG (41). 
Efforts to localize  the genetic  markers,  showed  that the isolated F(ab't)2 
fragment is lacking Gm(12),  but still  contains both Gm(1)  and Gin(4).  The 
presence of Gin(4) and the absence of Gm(12) are in agreement with previous 
reports (42), drawing conclusions about the location of various genetic markers 
on  the  IgG molecule  from studies of  the  enzymatic degradation products. 
On the other hand, the presence of Gm(1) on F(ab")2 may be due to one of two 
reasons.  One possibility  is that this marker is located on  the portion of the 
heavy chain between the locus of cleavage with papain and the locus of cleavage 
with CNBr, whereas  the Gin(12)  is located closer to the COOH terminus of 
the heavy chain. A corollary of this assumption is that the CNBr cleavage of 
the heavy chain occurs between the Gin(12)  and Gm(1)  markers.  The other 
possibility,  which cannot yet be excluded, is that the Gm(1) marker is on a 
peptide which was cleaved away from F(ab'02 by CNBr but was not completely 
removed thereafter. 
Another biological property investigated is the anticomplementary activity. 
IgG fractionated from serum is capable of nonspecifical binding of complement 
(43). Evidence has been presented (44, 45) that this effect is increased by arti- 
ficial aggregation  of the IgG, and therefore  it was assumed that presence  of 
aggregates is the cause of this complement fixation. Attempts to reduce  these 
effects have thus been concentrated either on efforts to remove such aggre- 802  CLEAVAGE  OF  HUMAN  IGGWITHCYANOGEN  BROMIDE 
gates by high speed centrifugation,  or by the use of low pH as a disaggregating 
means (43). Enzymatic fragmentation of the IgG by papaln led to fragments 
which were incapable of binding complement (39). On the other hand, aggrega- 
tion  experiments  demonstrated  that  Fc  alone  could form  aggregates  fixing 
complement. It seems,  thus,  that  the complement-fixing  capacity is inherent 
in the Fc portion of the IgG molecule,  and is not due to aggregation  per se. 
The results presented in this study sustain this hypothesis by demonstrating 
that the CNBr-digest product of IgG, in which Fc is presumably absent, has 
lost the anticomplementary activity of the original IgG, although it is not free 
of  aggregates  under  the  specified  experimental  conditions.  The  results  also 
demonstrate that, although acid treatment alone causes a marked loss of com- 
plement-binding  capacity,  the  effect of  CNBr  cleavage  is more pronounced 
(Fig. 6). 
Investigations carried out using  CNBr for cleavage of proteins,  were con- 
cerned mainly with structural and amino acid sequence studies.  The purpose 
of the present study was to obtain a fragment which will retain the antibody 
function of the starting immunoglobulin.  The mere fact that the isohemaggluti- 
nating  activity was preserved after CNBr cleavage of IgG containing  anti-A 
activity indicates  that  the  CNBr-produced  F(ab")~  fragment  is  indeed  di- 
valent. Thus it may be deduced that,  in resemblance to the rabbit IgG (13), 
human IgG may be cleaved by CNBr to yield a product similar to the one ob- 
tained by pepsin degradation. 
It has been suggested  that human IgG degraded with pepsin may be suit- 
able for intravenous administration (40). The observation presented here, that 
the main product of CNBr cleavage of human IgG under the conditions de- 
scribed,  kept its antibody activity, whereas it lost most of its hetero- and iso- 
antigenic  determinants,  as well as its capacity to bind complement and fix to 
skin,  suggests similarly  the advisability of testing CNBr-deaved human IgG 
for possible  therapeutic  uses.  The  advantage of using CNBr for cleavage of 
IgG is in its defined specificity and in the ease of removal of the reagent. 
sv-M~y 
Treatment  of  human  IgG  with  cyanogen bromide  in  0.05 u  HCI  under 
specified  conditions  resulted  in  the  cleavage of about half  of its methionyl 
peptide bonds. A major fragment of about 5S was isolated from the reaction 
mixture by gel filtration  in  quantitative  yield.  The  CNBr fragment reacted 
fully with goat  antiserum  against  human  light  chain,  but its  reaction with 
anti-heavy chain was markedly decreased.  The treatment with CNBr caused 
a  drastic  decrease  in  the following  biological  activities of IgG:  complement 
fixing, skin binding,  reaction with antiglobulin factors, and reaction with specific 
anti-Gin(12)  serum.  On the other hand, the reaction with serum of anti-Gin(I) 
or  anti-Gm(4)  specificity was  not  impaired  and  antibody  activity,  namely MIRA LAHAV, RUTH ARNON~ AND MICHAEL SELA  803 
antistreptolysin and isohemagglutinin,  was retained  after the treatment with 
CNBr. 
It is concluded that the CNBr cleaves preferentially the methionyl bonds in 
the Fc portion of IgG, and that the major fragment obtained, denoted F(ab~P)2, 
has still the combining properties of a  divalent antibody. The possible thera- 
peutic uses of F(ab'~)2 are discussed. 
The assistance of Mr. Ariel Lustig with the ultracentrifugal analyses, and of Miss Hanna 
Levinhar with the determination of genetic markers, is gratefully acknowledged. 
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